Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06905392 · ClinicalTrials.gov registry record
AQT90 FLEX NTproBNP2 Test Kit Matrix Comparison and Sample Stability Verification Study
A clinical trial, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- 154
- Enrollment target
NCT06905392: Completed study, sponsored by Radiometer Medical ApS.
NCT06905392 is a clinical trial that has completed, run by Radiometer Medical ApS. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06905392 has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the correlation between sample matrices, and to determine the sample stability for the NTproBNP2 Test Kit on the AQT90 FLEX analyzer.
Primary Outcome
To establish a correlation between sample matrices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2026-01-02 |
What the finished NCT06905392 record still lists
NCT06905392 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06905392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06905392 about?
NCT06905392 is a clinical study titled "AQT90 FLEX NTproBNP2 Test Kit Matrix Comparison and Sample Stability Verification Study". The purpose of this study is to establish the correlation between sample matrices, and to determine the sample stability for the NTproBNP2 Test Kit on the AQT90 FLEX analyzer.
What is the current status of trial NCT06905392?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2025-05-15. Estimated completion is 2026-01-02.
Who is sponsoring clinical trial NCT06905392?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI